tweenvest

XORTX Therapeutics Inc. (NasdaqCM: XRTX)

Health Care · Pharmaceuticals · CA

$1.06

0.00% today · -61.1% 1Y

Public summary
A free snapshot of XORTX Therapeutics Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

XORTX Therapeutics Inc. (NasdaqCM: XRTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.93M and employs 2 people.

Over the last twelve months the share price has lost 61.1%, trading between 0.83 and 3.60.

Tweenvest scores XORTX Therapeutics Inc. across four factors: quality 35/100, value 47/100. Its strongest factor is value.

XRTX price history

Nov 21, 2025 · 2.77Weekly closes 0.91 – 3.24Nov 18, 2026 · 1.06

Key figures

Market cap
$1.93M
Revenue (TTM)
—
P/E
-0.55
EPS
-2.29
Dividend yield
—
Beta (5Y)
0.81
52-week high
$3.60
52-week low
$0.83
Avg volume (3M)
—
Shares outstanding
1.82M
Employees
2
Next earnings
—

About XORTX Therapeutics Inc.

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kidney disease (ADPKD). Another key candidate is XRx-101, an agent aimed at reducing uric acid levels in COVID-19 patients, with the goal of mitigating acute kidney injury and related complications. Furthermore, they are developing XRx-221, a series of xanthine oxidase inhibitors intended for the management of diabetic nephropathy. XORTX also collaborates with the Icahn School of Medicine on research investigating acute kidney injury and hyperuricemia among hospitalized COVID-19 patients. The company's operations are headquartered in Vancouver, Canada.

ISIN
CA98420Q4051
Listed since
Sep 23, 2021
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Lasa Supergenerics LimitedNSEI: LASA$2.13MRs4.01-4.98%
Delex Healthcare Group Inc.OTCPK: DELX$2.10M$0.000.00%
Société des Industries Pharmaceutiques de Tunisie - S.A.BVMT: SIPHA$2.05MDT3.41+0.29%
Delivra Health Brands Inc.TSXV: DHB$1.97MCA$0.090.00%
Clearmind Medicine Inc.NasdaqCM: CMND$1.91M$4.53-1.95%
Cai Lay Veterinary Pharmaceutical Joint Stock CompanyHNX: MKV$1.89M₫9,700.00-9.35%
Zenith Healthcare LimitedBSE: 530665$1.88MRs3.30-4.07%
Venmax Drugs and Pharmaceuticals LimitedBSE: 531015$1.87MRs12.14-1.78%

Browse every Pharmaceuticals company →